Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Study: Raloxifene Prevents Breast Cancer

Posted on: Wednesday, 13 September 2006, 15:00 CDT

The drug raloxifene protects postmenopausal women from developing invasive breast cancer, found a U.S. study.

The study, published in the journal Clinical Cancer Research, found that the drug appears to reduce risk in women with a family history of breast cancer down to a similar level to women without affected relatives.

Compared with a placebo drug, the study also found that use of raloxifene was associated with a 58-percent reduction in breast-cancer risk in women without a family history of the disease and an 89-percent reduction in risk for women with a family history of breast cancer.

Lead author Dr. Marc E. Lippman of the University of Michigan said he cannot explain why protection seems greatest in women who may be genetically predisposed to develop the disease.

We don't know what to make of this observation, said Lippman. It could be due to chance, or there may be other factors at work that we don't know about.


Source: United Press International

More News in this Category


Related Articles



Rating: 3.3 / 5 (10 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required